• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    TIAN RUIXIANG Holdings Ltd Regains Compliance with Nasdaq Minimum Bid Price Requirement and Receives an Extension on Compliance with Nasdaq Filing Requirement

    6/3/24 8:30:00 AM ET
    $TIRX
    Specialty Insurers
    Finance
    Get the next $TIRX alert in real time by email

    BEIJING, June 03, 2024 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (NASDAQ:TIRX) (the "Company"), a China-based insurance broker conducting business through its variable interest entity in China, today announced that the Company received a written notification (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") on May 29, 2024, informing the Company that it has regained compliance with Nasdaq's minimum bid price requirement under Listing Rule 5550(a)(2). According to the Notification Letter, as of May 28, 2024, the Company has maintained a closing bid price of $1.00 per share or greater for ten consecutive business days.

    In addition, the Company received a letter from Nasdaq on May 29, 2024 (the "Extension Notice"), granting the Company an extension until August 15, 2024 to regain compliance with Nasdaq's filing requirements set forth in Listing Rule 5250(c)(1). As previously reported, the Company received a deficiency notice from Nasdaq on March 20, 2024, due to the delay in filing its Annual Report on Form 20-F for the fiscal year ended October 31, 2023. To rectify this situation, the Company has been working diligently with its auditors and anticipates that it will file the Annual Report before August 15, 2024, however, there is no assurance that it will be able to do so. If the Company fails to file Form 20-F by August 15, 2024, the Company will be subject to delisting. The Extension Notice does not affect the Company's business operations, its U.S. Securities and Exchange Commission reporting requirements, or its contractual obligations.

    About TIAN RUIXIANG Holdings Ltd

    TIAN RUIXIANG Holdings Ltd, headquartered in Beijing, China, is an insurance broker operating in China through its China-based variable interest entity. It distributes a wide range of insurance products, which are categorized into two major groups: (1) property and casualty insurance, such as automobile insurance, commercial property insurance, liability insurance; and (2) other insurance, such as life insurance and health insurance. For more information, visit the company's website at http://ir.tianrx.com/.

    Forward-Looking Statements

    Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "is/are likely to" or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review risk factors that may affect its future results in the Company's registration statement and in its other filings with the U.S. Securities and Exchange Commission.

    For investor and media enquiries, please contact:

    TIAN RUIXIANG Holdings Ltd

    Investor Relations Department

    Email: [email protected]

    Wealth Financial Services LLC

    Connie Kang

    Partner

    Email: [email protected]

    Tel: +86 1381 185 7742 (CN)



    Primary Logo

    Get the next $TIRX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TIRX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $TIRX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    TIAN RUIXIANG Unveils unprecedented Asia-Pacific AI Healthcare Revolution: Strategic Partnership & Acquisition of Singapore's Top 3 Medical Leaders to Dominate AI-Driven Diagnostics Across Southeast Asia

    Beijing/Singapore, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Tian Ruixiang Holdings Limited ("Tianruixiang" or the "Company") (NASDAQ:TIRX), a global trailblazer in AI-powered insurance innovation, today announced a landmark expansion of its transformative ecosystem, cementing its position as the undisputed leader in AI-driven healthcare across Southeast Asia and the Asia-Pacific. Building on its historic AI initiative with top-tier global insurance firms, TIRX has entered into strategic partnership and acquisition discussions with Singapore's top three medical technology leaders, a move set to redefine the future of insurance-clinic integration and precision diagnostics in the region. The propo

    2/12/26 9:32:41 AM ET
    $TIRX
    Specialty Insurers
    Finance

    TIAN RUIXIANG Unleashes Unprecedented Asian Financial Domination: 15,000 BTC Alliance Launches Dual Assault—Historic ASEAN Stablecoin Dominance & $200 billion Australian Licensed Bank Takeover

    Beijing, Feb. 09, 2026 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd. (NASDAQ:TIRX) as the undisputed titan of AI-powered digital and traditional finance, the Nasdaq-listed juggernaut today detonated a seismic double-barreled plan: its game-changing 15,000 Bitcoin ("BTC") strategic alliance is not only barreling toward regulatory victory for a government-backed stablecoin empire across Southeast Asia's economic powerhouses—but is simultaneously executing a landmark, industry-redefining acquisition of a fully licensed Australian bank with a staggering $200 billion in total assets, merging crypto's revolutionary firepower with the unshakable credibility of regulated traditional banking to

    2/9/26 9:15:00 AM ET
    $TIRX
    Specialty Insurers
    Finance

    TIAN RUIXIANG Ignites a Digital Financial Revolution: 15,000 BTC Powerhouse Alliance Surges Toward Historic Government-backed Stablecoin Issuance Dominance in Key Southeast Asia Countries

    Beijing, Feb. 06, 2026 (GLOBE NEWSWIRE) -- In a seismic move set to redefine the global digital asset landscape and crown a new era of AI-driven crypto supremacy, TIAN RUIXIANG Holdings Ltd. (NASDAQ:TIRX, the "Company")) — today dropped a bombshell update: its epoch-making partnership with a titanic global digital asset investor, forged with a 15,000 Bitcoin ("BTC") injection, has erupted into a game-changing stablecoin initiative, now hurtling through the decisive and mature stretch of negotiations with government leaders across Southeast Asia's most influential nations. This is not merely an expansion — it is a full-throttle charge to seize control of the world's fastest-growing digital

    2/6/26 9:15:00 AM ET
    $TIRX
    Specialty Insurers
    Finance

    $TIRX
    SEC Filings

    View All

    SEC Form 6-K filed by TIAN RUIXIANG Holdings Ltd

    6-K - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Filer)

    2/12/26 4:30:05 PM ET
    $TIRX
    Specialty Insurers
    Finance

    SEC Form 6-K filed by TIAN RUIXIANG Holdings Ltd

    6-K - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Filer)

    2/5/26 9:15:24 AM ET
    $TIRX
    Specialty Insurers
    Finance

    SEC Form SCHEDULE 13G filed by TIAN RUIXIANG Holdings Ltd

    SCHEDULE 13G - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Subject)

    2/4/26 4:21:04 PM ET
    $TIRX
    Specialty Insurers
    Finance

    $TIRX
    Leadership Updates

    Live Leadership Updates

    View All

    TIAN RUIXIANG Holdings Ltd to Acquire Ucare Inc. in US$150 Million All-Stock Deal, Advancing In-Hospital Health Insurance Strategy

    BEIJING, May 30, 2025 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (NASDAQ:TIRX) (the "Company" or "TRX"), a China-based insurance broker, today announced plans to acquire 100% of issued and outstanding shares of Ucare Inc. ("Ucare"), the sole operator of China's only cloud-based AI-driven hospital and health insurance risk management platform, in an all-share deal valued at US$150 million. This strategic move aims to unlock new growth opportunities in the health insurance segment. The Company and its wholly-owned subsidiary, VitaCare Limited ("VitaCare") have entered into a share exchange agreement (the "Agreement") with certain shareholders (the "Sellers") of Ucare and other parties.

    5/30/25 6:10:00 AM ET
    $TIRX
    Specialty Insurers
    Finance

    $TIRX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by TIAN RUIXIANG Holdings Ltd

    SC 13G/A - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Subject)

    11/13/24 11:16:48 AM ET
    $TIRX
    Specialty Insurers
    Finance

    SEC Form SC 13D filed by TIAN RUIXIANG Holdings Ltd

    SC 13D - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Subject)

    6/10/24 6:15:45 AM ET
    $TIRX
    Specialty Insurers
    Finance

    SEC Form SC 13D/A filed by TIAN RUIXIANG Holdings Ltd (Amendment)

    SC 13D/A - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Subject)

    6/10/24 6:08:20 AM ET
    $TIRX
    Specialty Insurers
    Finance

    $TIRX
    Financials

    Live finance-specific insights

    View All

    Water Tower Research Publishes Initiation of Coverage Report on Tian Ruixiang Holdings Limited, "From Traditional Insurance Broker to Tech-Based Health Insurance Innovator"

    ST. PETERSBURG, FL, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Water Tower Research (www.watertowerresearch.com) has published an Initiation of Coverage Report on Tian Ruixiang Holdings Limited (NASDAQ:TIRX) titled, "From Traditional Insurance Broker to Tech- Based Health Insurance Innovator". The report can be accessed here. Access to China's growing health insurance market. On June 30, 2025, Chinese insurance broker Tian Ruixiang Holdings Limited completed the acquisition of Ucare, which describes itself as the only cloud-based healthcare value assessment and insurance risk control SaaS platform in China, for total all-stock consideration of $150 million. Ucare's wealth of AI-driven analytics st

    8/7/25 12:00:00 PM ET
    $TIRX
    Specialty Insurers
    Finance

    TIAN RUIXIANG Holdings Ltd Completes Acquisition of Ucare Inc., Marking Strategic Expansion into AI-Powered Health Insurance Solutions

    BEIJING, June 30, 2025 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (NASDAQ:TIRX) (the "Company" or "TRX"), a China-based insurance broker, today announced it has completed the acquisition of 100% of issued and outstanding shares of Ucare Inc. ("Ucare"), the sole operator of China's only cloud-based AI-driven hospital and health insurance risk management platform. The all-stock transaction, valued at US$150 million, marks a major milestone in TRX's strategy to expand into in-hospital distribution channels and capture new growth opportunities within the health insurance sector. As part of the closing, TRX has issued 101,486,575 Class A ordinary shares, each with a par value of US$0.025

    6/30/25 3:05:00 PM ET
    $TIRX
    Specialty Insurers
    Finance

    TIAN RUIXIANG Holdings Ltd Reports Financial Results for the Half Year Ended April 30, 2024

    BEIJING, Aug. 16, 2024 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (NASDAQ:TIRX) (the "Company"), a China-based insurance broker conducting business through its variable interest entity in China, today announced its financial results for the half year ended April 30, 2024. Ms. Sheng Xu, the Chief Executive Officer of the Company, commented, "The Company reported a net loss of approximately $2.6 million for the six months ended April 30, 2024, primarily due to a significant decline in revenue caused by the loss of a few key insurance company partners. However, we are encouraged by the increase in the commissions from liability insurance of approximately $24,000 compared to t

    8/16/24 4:15:15 PM ET
    $TIRX
    Specialty Insurers
    Finance